Shenzhen New Industries Biomedical Engineering News and Activities

Shenzhen New Industries Biomedical Engineering is one of the...

• CSI 300;
• TOB Iconic 10,000.

Shenzhen New Industries Biomedical Engineering is a company listed under the stock ticker 300832 (CN).

View the org chart displaying its 5 main executives

Most searched biographies at Shenzhen New Industries Biomedical Engineering

• Wei Rao, Chairman and General Manager
• Rao Wei, Non-Independent Director
• Rao Jie, Non-Independent Director

Create your alert
to follow the executive moves at Shenzhen New Industries Biomedical Engineering.

Shenzhen New Industries Biomedical Engineering has 2,405 competitors including Eurofins (Luxembourg), Lonza (Switzerland) and BioNTech (Germany).

Popular M&A news in Biotechnology

• Ona Therapeutics has just announced a $87 Million fundraising (posted on June 5 2026).
• Laboratoire Servier has announced the acquisition of Edgewise Therapeutics  (posted on June 4 2026).
• Oak Hill Bio has just announced a $33 Million fundraising (posted on June 4 2026).

Popular contacts in Biotechnology

• Jakob Uszkoreit - Co-Founder and Chief Executive Officer at Inceptive
• Jan Van de Winkel - President and Chief Executive Officer at Genmab
• Patrick Enright - Director at CuraSen Therapeutics

Learn more about the Biotechnology industry

Press releases by Shenzhen New Industries Biomedical Engineering

Social media about Shenzhen New Industries Biomedical Engineering

• Shenzhen New Industries Biomedical Engineering on Wikipedia, Google News & Yahoo Finance
• Shenzhen New Industries Biomedical Engineering on LinkedIn, X (Twitter) & YouTube